Google
NVNO — ENVVENO MEDICAL CORP (Healthcare >> Medical Devices)
NVNO FAQ
What is NVNO's ROE?
ENVVENO MEDICAL CORP reports a Return on Equity (ROE) of -79.24%.
What is NVNO's dividend yield?
ENVVENO MEDICAL CORP offers a dividend yield of 0.00%.
What is NVNO's Deepscope Quality Score?
Deepscope rates NVNO's overall financial quality at 8 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy NVNO?
Deepscope's AI Timing Score for NVNO is 51 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does NVNO belong to?
ENVVENO MEDICAL CORP is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 10.75
Price
0.04
(0.38%)
Day Change
|
|
|---|
NVNO, the overall quality is not good ( Quality = 8) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 10.75 |
| PBV / Sector |
0.30 / 7.50
GREAT
|
| Earning Per Share | -28.18 |
| PE / Sector |
N/A / 28.68
|
| PEG or PE/Growth / Sector |
N/A / 0.39
|
| Average 1M Daily Value |
0.11 M
GREAT
|
| Average 1W Daily Value |
0.09 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-05 09:11:54 |
| Symbol | NVNO |
| Name | ENVVENO MEDICAL CORP |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 0.67 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 7.18 / 18,060.39 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 70 Doppler, Irvine, CA, United States, 92618
Phone: 949 261 2900
Website: https://www.envveno.com
Sector: Healthcare >> Medical Devices
Description: enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
